REDWOOD SHORES, CA – February 10, 2016 – Boosting clinical development productivity and efficiency is a top priority for life sciences organizations. To that end, Oracle today announced that two of its core Health Sciences offerings - Oracle Siebel Clinical Trial Management System and Oracle Health Sciences Clinical Development Analytics - have been selected by Bayer HealthCare, to oversee and manage the company’s clinical monitoring processes. Bayer HealthCare, a subgroup of Bayer AG researches, develops, manufactures, and markets pharmaceutical and medical products.
Oracle’s life sciences-specific solutions, combined with its broader product and service offering, are used by thousands of pharma, biopharma, and academic research centers worldwide to redesign clinical R&D processes, advance drug therapies, and optimize care delivery to improve the health, well-being, and lives of people globally.
“Oracle Health Sciences is committed to helping organizations, such as Bayer HealthCare, advance its vision of innovation to drive faster, safer, and more cost-effective therapies and treatments to improve lives around the globe,” said Steve Rosenberg, senior vice president and general manager, Oracle Health Sciences. “Our proven solutions are helping industry leaders, as well as emerging organizations, power innovation across the clinical development lifecycle.”
Oracle Siebel Clinical Trial Management System manages and monitors clinical testing sites for any issues as they arise. Oracle Health Sciences Clinical Development Analytics provides an effective platform that optimizes actionable, clinical analytics, addresses compliance issues, and monitors resources. Together, these solutions give clinical research associates greater visibility into site performance, with the ability to track open issues to resolution and manage risk.
Oracle Health Sciences’ advanced clinical trial solutions for data collection, management, and analysis help optimize research, mitigate risk, monitor/report adverse events, and drive medical insight for precision medicine
Additional Information
To learn more about Oracle Health Sciences, please follow @OracleHealthSci and Oracle Health Sciences.
About Oracle
Oracle offers a comprehensive and fully integrated stack of cloud applications and platform services. For more information about Oracle (NYSE:ORCL), visit oracle.com.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.